跳至主要内容
临床试验/NCT01833975
NCT01833975Unknown1 期

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury . It is Self Funded (Patients' Own Funding) Clinical Trial

Chaitanya Hospital, Pune2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
50
试验地点
2
主要终点
Improvement in overall sensory for motor control using Frankel score.

研究概览

简要总结

This Study is a single arm,Phase I/II , single centre trial to check active comparing the safety and efficacy of Bone marrow derived autologous cell(100 million per dose) trial to be conducted for 36 months.

详细描述

A spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease.[1] Depending on where the spinal cord and nerve roots are damaged, the symptoms can vary widely, from pain to paralysis to incontinence.[2][3] Spinal cord injuries are described at various levels of "incomplete", which can vary from having no effect on the patient to a "complete" injury which means a total loss of function.Injuries at any level can cause:Increased muscle tone (spasticity),Loss of normal bowel and bladder control (may include constipation, incontinence, bladder spasms),Numbness,Sensory changes Pain,Weakness, paralysis. This Study is a single arm,Phase I/II , single centre trial to check active comparing the safety and efficacy of Bone marrow derived autologous cell(100 million per dose) trial to be conducted for 36 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient should suffer from Spinal cord injury.
  • willingness to undergo bone marrow derived autologous cell therapy.
  • patient those provide fully Informed consent form for the study.
  • Ability and willingness to regular visit to hospital and follow up during the protocol Procedures.
  • traumatic Injury of spinal cord with complete or partial damage by MRI and Spinal cord injury level should be below C4

排除标准

  • Patient with pre- existing or current systemic disease such as Lung, liver,(exception:history of uncomplicated hepatitis A)gastrointestinal,cardiac , immunodeficiency(HIV)
  • History of life threatening allergic or immune - mediated reaction.
  • haemodynamically unstable patients.
  • patient suffer from peripheral muscular dystrophy.
  • lactating and pregnant woman
  • alcohol drug abuse /dependence
  • positive test result for hepatitis A and Hepatitis B OR C
  • Major-traumatic brain injury and patient with psychiatric illness .

结局指标

主要结局

Improvement in overall sensory for motor control using Frankel score.

时间窗: 6 month

次要结局

  • Improvement in pain sensation and Significant changes in Muscle Tones from base line(6 month)
  • -Improvement in sensory and motor dysfunction using ASIA( American spinal cord injury association ) Scale(6 month)
  • Significant changes in Muscle Tones and Improvement in pain sensation from base line(6 month)

研究者

发起方
Chaitanya Hospital, Pune
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Sachin Jamadar

C0- Investigator

Chaitanya Hospital, Pune

研究点 (2)

Loading locations...

相似试验

Study the Safety and Efficacy of Bone Marrow Derived... | 临床试验